Your browser doesn't support javascript.
loading
Continuous infusion of beta-lactam antibiotics in pediatric intensive care unit: A monocenter before/after implementation study.
Ragonnet, Gwendoline; Guilhaumou, Romain; Hanafia, Omar; Néant, Nadège; Denante, Solène; Vanel, Noémie; Honoré, Stéphane; Michel, Fabrice.
Afiliación
  • Ragonnet G; Pharmacie à Usage Intérieur Centre Hospitalo-Universitaire Timone, 13385 Marseille Cedex 5, France. Electronic address: gwendoline.ragonnet@ap-hm.fr.
  • Guilhaumou R; Aix Marseille Univ, APHM, Institut des Neurosciences des Systèmes, Inserm UMR 11600, Service de Pharmacologie Clinique et PharmaSurveillance, 13385 Marseille Cedex 5, France.
  • Hanafia O; Pharmacie à Usage Intérieur Centre Hospitalo-Universitaire Timone, 13385 Marseille Cedex 5, France.
  • Néant N; Laboratoire de Pharmacocinétique et Toxicologie, 13385 Marseille Cedex 5, France.
  • Denante S; Réanimation Pédiatrique Centre Hospitalo-universitaire Timone, 13385 Marseille Cedex 5, France.
  • Vanel N; Réanimation Pédiatrique Centre Hospitalo-universitaire Timone, 13385 Marseille Cedex 5, France.
  • Honoré S; Pharmacie à Usage Intérieur Centre Hospitalo-Universitaire Timone, 13385 Marseille Cedex 5, France; Aix Marseille Univ, EA 3279, CEReSS, Research Centre on Health Services and Quality of Life, Observatoire des Médicaments, Dispositifs Médicaux et Innovations Thérapeutiques (OMéDIT PACA Corse), Marse
  • Michel F; Réanimation Pédiatrique Centre Hospitalo-universitaire Timone, 13385 Marseille Cedex 5, France.
Anaesth Crit Care Pain Med ; 43(3): 101354, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38360404
ABSTRACT
CONTEXT Beta-lactam continuous infusion (CI) is currently recommended in adult intensive care units to achieve target concentrations. In pediatric intensive care (PICU), few studies suggest the value of Beta-lactam CI to achieve target concentration. Our objective was to analyze the impact of Beta-lactam CI protocolization on the achievement of target concentration in PICU patients. MATERIAL AND

METHODS:

We conducted a single-center retrospective study in patients with beta-lactam treatment for more than 2 days and at least one sample for therapeutic drug monitoring (TDM). From January 2018 to February 2022 (period 1, P1), BL were administered as an intermittent infusion with TDM upon request. From February to September 2022 (period 2, P2), Beta-lactam CI with TDM at day one was protocolized. The primary endpoint concerned achieving fT>4× Minimum Inhibitory Concentration = 100%.

RESULTS:

In P1, 214 assays involved 103 patients; in P2, 199 assays involved 72 patients. Target concentration achievement was more frequent in P2 (P2 = 73.7% vs. P1 = 29.1%; p < 0.001). At day 5/6 after Beta-lactam initiation, c-reactive protein concentrations were P1 = 84.9 ± 79.2 mg/L; P2 = 53.7±49.8 mg/L (p < 0.05). In the multivariable logistic regression model P2, BSA, and albumin were positively associated with target achievement; urea, and male sex were negatively associated with target achievement. The daily average cost of beta-lactam vial consumption per child was P1 = 5.04 ± 2.6 ; vs. P2 = 3.21 ± 2.7 ; (p-value < 0.001). The daily average reconstitution time of Beta-lactam syringes per child was P1 = 23.5 ± 8.7 min, P2 = 13.9 ± 9.2 min (p-value < 0.001).

CONCLUSION:

Protocolization of Beta-lactam continuous infusion was associated with more frequent target concentration achievements in PICU. This implementation could be cost-effective and nurse time-saving.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Unidades de Cuidado Intensivo Pediátrico / Monitoreo de Drogas / Beta-Lactamas / Antibacterianos Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Anaesth Crit Care Pain Med Año: 2024 Tipo del documento: Article Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Unidades de Cuidado Intensivo Pediátrico / Monitoreo de Drogas / Beta-Lactamas / Antibacterianos Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Anaesth Crit Care Pain Med Año: 2024 Tipo del documento: Article Pais de publicación: Francia